ENDOMETRIOSIS: ETIOPATHOGENESIS, EPIDEMIOLOGY, DIAGNOSIS AND THE CURRENT STATE OF TREATMENT (LITERATURE REVIEW AND STATISTICAL ANALYSIS)
Keywords:
endometriosis, retrograde menstruation, chronic pelvic pain, infertility, laparoscopy, rASRM classification, hormonal therapy, GnRH antagonists, quality of life, disease burden.Abstract
This article provides a systematic review and statistical analysis of contemporary scientific data on endometriosis, covering its epidemiology, etiopathogenetic theories, diagnostic approaches and treatment strategies. Statistical evidence from the Global Burden of Disease (GBD) studies, meta-analyses and major clinical trials is synthesized. Endometriosis affects approximately 10% of women of reproductive age, with a mean diagnostic delay of 6.6–9.7 years, and infertility observed in 30–40% of patients. The efficacy and limitations of hormonal therapy (progestins, GnRH agonists and antagonists), surgery and assisted reproductive technologies are compared. The detrimental impact of the disease on quality of life and the economy is substantiated by statistical data.
References
1.Harder C., et al. Assessing the true prevalence of endometriosis: A narrative review of literature data // International Journal of Gynecology & Obstetrics. — 2024.
2.GBD 2021. Global, regional, and national burden of endometriosis among women of reproductive age, 1990–2021 // Frontiers in Global Women’s Health. — 2025.
3.Global prevalence of adenomyosis and endometriosis: a systematic review and meta-analysis // PubMed (PMID: 41257733). — 2025.
4.Taylor H.S., Kotlyar A.M., Flores V.A. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations // The Lancet. — 2021. — Vol. 397. — P. 839–852.
5.Zondervan K.T., Becker C.M., Missmer S.A. Endometriosis // New England Journal of Medicine. — 2020. — Vol. 382, No. 13. — P. 1244–1256.
6.Sampson J.A. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity // American Journal of Obstetrics and Gynecology. — 1927. — Vol. 14. — P. 422–469.
7.De Corte P., et al. Time to Diagnose Endometriosis: Current Status, Challenges and Regional Characteristics — A Systematic Literature Review // BJOG. — 2024/2025.
8.Taylor H.S., Giudice L.C., Lessey B.A., et al. Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist // New England Journal of Medicine. — 2017. — Vol. 377. — P. 28–40.
9.ESHRE Endometriosis Guideline Group. ESHRE guideline: endometriosis // Human Reproduction Open. — 2022.
10.Simoens S., Dunselman G., Dirksen C., et al. The burden of endometriosis: costs and quality of life of women with endometriosis treated in referral centres // Human Reproduction. — 2012. — Vol. 27, No. 5. — P. 1292–1299.
11.Practice Committee of ASRM. Endometriosis and infertility: a committee opinion // Fertility and Sterility. — 2012.
12.Vercellini P., Viganò P., Somigliana E., Fedele L. Endometriosis: pathogenesis and treatment // Nature Reviews Endocrinology. — 2014. — Vol. 10. — P. 261–275.




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal